Free Trial

Soleno Therapeutics (SLNO) SEC Filings & 10K Form

Soleno Therapeutics logo
$54.96 +0.13 (+0.24%)
(As of 10:17 AM ET)

Recent Soleno Therapeutics SEC Filings

DateFilerForm TypeView
11/19/2024
8:44 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
11/14/2024
8:36 AM
Avoro Capital Advisors LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
11/12/2024
8:33 AM
Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
11/06/2024
3:06 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:44 PM
BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/21/2024
3:30 PM
Abingworth Bioventures VII LP (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
3:31 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/15/2024
3:31 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/10/2024
3:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/03/2024
4:53 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:55 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:02 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:03 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:55 AM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
09/10/2024
5:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
09/05/2024
5:37 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
08/30/2024
5:33 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:34 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:35 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:36 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
6:36 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:14 PM
Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2024
6:16 PM
Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
5:16 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
5:18 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:55 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:56 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:56 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:18 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:54 PM
Soleno Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
3:00 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:02 PM
Soleno Therapeutics (Filer)
Form 424B5
07/19/2024
4:04 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
8:00 AM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:01 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
8:01 AM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:02 AM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:02 AM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:03 AM
Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
07/19/2024
8:04 AM
Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:56 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:58 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:58 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
5:00 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:13 PM
Melincoff Gwen A (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:17 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:49 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:50 PM
Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:51 PM
Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:52 PM
Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:46 PM
Harris William G (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:29 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
6:11 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:28 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
12:07 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13D/A
05/01/2024
12:10 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:53 PM
Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
4:54 PM
Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2024
4:06 PM
Soleno Therapeutics (Filer)
Form ARS
04/22/2024
3:31 PM
Soleno Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:15 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
8:36 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:37 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:39 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:40 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:06 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:35 PM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
02/07/2024
7:01 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:57 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:42 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:44 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:47 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:31 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:34 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:35 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:36 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:37 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:16 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
5:00 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
6:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:09 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
8:32 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:32 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:34 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:34 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:46 PM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
3:53 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:17 PM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
6:05 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here
12/11/2023
6:21 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
7:41 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:02 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:03 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:04 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:06 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:50 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:51 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:52 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLNO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners